News: Actinium to Present at Rodman & Renshaw 17th
Post# of 98
Posted On: 09/02/2015 7:28:45 AM
News: Actinium to Present at Rodman & Renshaw 17th Annual Global Investment Conference
Marketwired
Related Quotes
.
ATNM2.11+0.48%
Actinium Pharmaceuticals, Inc. Watchlist
2.11+0.01(+0.48%)
AMEXTue, Sep 1, 2015 4:00 PM EDT
ACTINIUM PHARMACEUTICALS, INC. Financials
EDGAR Online Financials 13 days ago
ACTINIUM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online 25 days ago
More
.
NEW YORK, NY--(Marketwired - September 02, 2015) - Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) ("Actinium" or "the Company"
, a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that it will be presenting at the Rodman & Renshaw 17th Annual Global Investment Conference, held September 8-10, 2015 at the St. Regis Hotel, New York City.
Event: Rodman & Renshaw 17thAnnual Global Investment Conference
Location: St. Regis Hotel, NYC
Date: September 10, 2015
Webcast: http://wsw.com/webcast/rrshq25/atnm
Actinium's Executive Chairman, Sandesh Seth, will deliver the Company's corporate presentation and discuss its recent business highlights. In addition to the presentation, Mr. Seth will also be available for one-on-one meetings.
Members of the investment community who are interested in meeting with Actinium's management should please contact Robert Haag at atnm@irthcommunications.com or 1-866-976-4784. Please visit this link to schedule a one-on-one scheduling directly.
About Rodman & Renshaw Conferences, LLC
The Rodman & Renshaw Annual Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC, is held on September 8 through September 10, 2015 at the St. Regis Hotel in New York. More than 200 public & private companies from around the world are expected to present to an audience of over 2,000 attendees. The event will feature tracks devoted to Biotechnology/Healthcare, Metals & Mining, Technology, Cleantech and Growth. The Conference will include corporate presentations and Q&A sessions, investor one-on-one meetings and daily networking opportunities.
http://finance.yahoo.com/news/actinium-presen...00117.html
Marketwired
Related Quotes
.
ATNM2.11+0.48%
Actinium Pharmaceuticals, Inc. Watchlist
2.11+0.01(+0.48%)
AMEXTue, Sep 1, 2015 4:00 PM EDT
ACTINIUM PHARMACEUTICALS, INC. Financials
EDGAR Online Financials 13 days ago
ACTINIUM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online 25 days ago
More
.
NEW YORK, NY--(Marketwired - September 02, 2015) - Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) ("Actinium" or "the Company"
, a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that it will be presenting at the Rodman & Renshaw 17th Annual Global Investment Conference, held September 8-10, 2015 at the St. Regis Hotel, New York City. Event: Rodman & Renshaw 17thAnnual Global Investment Conference
Location: St. Regis Hotel, NYC
Date: September 10, 2015
Webcast: http://wsw.com/webcast/rrshq25/atnm
Actinium's Executive Chairman, Sandesh Seth, will deliver the Company's corporate presentation and discuss its recent business highlights. In addition to the presentation, Mr. Seth will also be available for one-on-one meetings.
Members of the investment community who are interested in meeting with Actinium's management should please contact Robert Haag at atnm@irthcommunications.com or 1-866-976-4784. Please visit this link to schedule a one-on-one scheduling directly.
About Rodman & Renshaw Conferences, LLC
The Rodman & Renshaw Annual Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC, is held on September 8 through September 10, 2015 at the St. Regis Hotel in New York. More than 200 public & private companies from around the world are expected to present to an audience of over 2,000 attendees. The event will feature tracks devoted to Biotechnology/Healthcare, Metals & Mining, Technology, Cleantech and Growth. The Conference will include corporate presentations and Q&A sessions, investor one-on-one meetings and daily networking opportunities.
http://finance.yahoo.com/news/actinium-presen...00117.html
(0)
(0)Actinium Pharmaceuticals, Inc. (ATNM) Stock Research Links
Scroll down for more posts ▼